Home » Topics » BioWorld Science

BioWorld Science
RSS

The exerkine apelin reverses age-associated sarcopenia

Aug. 9, 2018

Activin signaling underscores resistance to platinum-based chemotherapy in lung adenocarcinoma

Aug. 9, 2018

Plugging leaks in engineered vasculature

Aug. 9, 2018

New biological target for Alzheimer's identified in BioArctic/Eisai collaboration

Aug. 8, 2018

Teneobio and Poseida to use UniDabs to develop CAR-T therapies

Aug. 8, 2018

Aged rhesus monkey shows same pattern of tau pathology as humans

Aug. 8, 2018

New sulfonamide is potent anti-breast cancer agent

Aug. 8, 2018

Recruitment underway in TaiRx's phase II study of CMV-118 in combination with sorafenib

Aug. 8, 2018

DMC recommends early continuation of phase III GENESIS study of BL-8040

Aug. 8, 2018

ADC Therapeutics begins dosing in registrational phase II trial evaluating ADCT-402

Aug. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...